Solana Co income statement
In fiscal 2025, Solana Co reported revenue of $6.0m, up 1057.1% on the year before, operating income of −$244m (a -4052.5% margin) and net income of −$40.9m, or −$1.85 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | 12 |
| Cost of revenue | — | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Gross profit | 0 | 1 | 0 | 0 | 0 | 0 | −0 | 6 | 12 |
| Research and development | 10 | 8 | 5 | 6 | 4 | 3 | 4 | 4 | — |
| Selling, general and administrative | 17 | 17 | 10 | 12 | 11 | 9 | 10 | 23 | — |
| Operating income | −27 | −24 | −14 | −18 | −16 | −12 | −14 | −244 | −369 |
| Income before tax | 29 | 10 | −14 | −18 | −14 | −9 | −12 | −41 | −157 |
| Income tax | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | −29 | −10 | −14 | −18 | −14 | −9 | −12 | −41 | −157 |
| Diluted EPS | −$860.34 | −$633550.56 | −$230.20 | −$287.95 | −$2606.50 | −$14.56 | −$3282.26 | −$1.85 | — |
| Diluted shares (average) | — | — | — | — | — | — | 4m | 22m | — |
| EBITDA | −27 | −24 | −14 | −18 | −15 | −12 | −14 | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 1 | 5 | 4 | 3 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | −0 | −0 | −0 | −0 | 1 | 5 | 3 | 2 |
| Research and development | 1 | 1 | 1 | 1 | 1 | 1 | — | — |
| Selling, general and administrative | 3 | 2 | 3 | 2 | 5 | 13 | — | — |
| General and administrative | — | — | — | — | — | — | 5 | 11 |
| Operating income | −4 | −3 | −4 | −3 | −35 | −201 | −100 | −33 |
| Income before tax | −4 | −4 | −4 | −10 | −353 | 326 | −100 | −30 |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | −4 | −4 | −4 | −10 | −353 | 326 | −100 | −30 |
| Diluted EPS | −$744.35 | −$774.45 | −$382.29 | −$79.73 | −$32.89 | $88.29 | −$1.30 | −$0.38 |
| EBITDA | −4 | −3 | −4 | −3 | — | — | — | — |
Compare with peers
- Nano-x Imaging Ltd. income statement
- Inspiremd, Inc. income statement
- Work Medical Technology Group LTD income statement
- Neuroone Medical Technologies Corp income statement
- Spectral AI, Inc. income statement
Head to head: HSDT vs NNOXHSDT vs NSPRHSDT vs WOK
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies